ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986

Obama Picks Daschle for HHS Secretary. Waxman Gains Chairmanship of Energy & Commerce.

November 21, 2008